248 related articles for article (PubMed ID: 2997417)
1. Technetium-99m NGA functional hepatic imaging: preliminary clinical experience.
Stadalnik RC; Vera DR; Woodle ES; Trudeau WL; Porter BA; Ward RE; Krohn KA; O'Grady LF
J Nucl Med; 1985 Nov; 26(11):1233-42. PubMed ID: 2997417
[TBL] [Abstract][Full Text] [Related]
2. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model.
Kudo M; Vera DR; Trudeau WL; Stadalnik RC
J Nucl Med; 1991 Jun; 32(6):1177-82. PubMed ID: 2045931
[TBL] [Abstract][Full Text] [Related]
3. Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography.
Kwon AH; Matsui Y; Ha-Kawa SK; Kamiyama Y
Am J Gastroenterol; 2001 Feb; 96(2):541-6. PubMed ID: 11232703
[TBL] [Abstract][Full Text] [Related]
4. Tc-NGA imaging in liver transplantation: preliminary clinical experience.
Woodle ES; Ward RE; Stadalnik RC; Vera DR
Surgery; 1989 Mar; 105(3):401-7. PubMed ID: 2646744
[TBL] [Abstract][Full Text] [Related]
5. Functional liver imaging with 99Tcm-galactosyl-neoglycoalbumin (NGA) in alcoholic liver cirrhosis and liver fibrosis.
Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
Nucl Med Commun; 1991 Jun; 12(6):507-17. PubMed ID: 1866104
[TBL] [Abstract][Full Text] [Related]
6. Tc-NGA imaging in liver transplantation: preclinical studies.
Woodle ES; Vera DR; Stadalnik RC; Ward RE
Surgery; 1987 Jul; 102(1):55-62. PubMed ID: 3296267
[TBL] [Abstract][Full Text] [Related]
7. Tc-99m galactosyl-neoglycoalbumin hepatic scintigraphy in fulminant hepatic failure.
Moragas M; Pavía J; Ginés A; Ros D; Solá M; Huguet M; Pons F; Setoain J
Clin Nucl Med; 1995 Apr; 20(4):329-33. PubMed ID: 7788990
[TBL] [Abstract][Full Text] [Related]
8. Distinction between hepatic focal nodular hyperplasia and malignant liver lesions using technetium-99m-galactosyl-neoglycoalbumin.
Kurtaran A; Müller C; Novacek G; Kaserer K; Mentes M; Raderer M; Pidlich J; Eibenberger K; Angelberger P; Virgolini I
J Nucl Med; 1997 Dec; 38(12):1912-5. PubMed ID: 9430468
[TBL] [Abstract][Full Text] [Related]
9. Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes.
Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
Radiology; 1984 Apr; 151(1):191-6. PubMed ID: 6701314
[TBL] [Abstract][Full Text] [Related]
10. Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding.
Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
J Nucl Med; 1984 Jul; 25(7):779-87. PubMed ID: 6737077
[TBL] [Abstract][Full Text] [Related]
11. Functional hepatic imaging with receptor-binding radiopharmaceutical: clinical potential as a measure of functioning hepatocyte mass.
Kudo M; Todo A; Ikekubo K; Hino M; Yonekura Y; Yamamoto K; Torizuka K
Gastroenterol Jpn; 1991 Dec; 26(6):734-41. PubMed ID: 1662653
[TBL] [Abstract][Full Text] [Related]
12. Comments on radionuclide hepatic scanning.
Rothschild MA; Oratz M; Schreiber SS
Semin Liver Dis; 1982 Feb; 2(1):29-40. PubMed ID: 7051317
[No Abstract] [Full Text] [Related]
13. Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin.
Vera DR; Woodle ES; Stadalnik RC
J Nucl Med; 1989 Sep; 30(9):1519-30. PubMed ID: 2549225
[TBL] [Abstract][Full Text] [Related]
14. Quantification of human hepatic binding protein (HBP) via 99mTc-galactosyl-neoglycoalbumin (NGA) liver scintigraphy.
Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
Wien Klin Wochenschr; 1991; 103(15):458-61. PubMed ID: 1926872
[TBL] [Abstract][Full Text] [Related]
15. Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand.
Virgolini I; Müller C; Klepetko W; Angelberger P; Bergmann H; O'Grady J; Sinzinger H
Br J Cancer; 1990 Jun; 61(6):937-41. PubMed ID: 2164838
[TBL] [Abstract][Full Text] [Related]
16. Hepatic scintigraphy.
Goldstein HA
Lab Res Methods Biol Med; 1983; 7():277-87. PubMed ID: 6353107
[No Abstract] [Full Text] [Related]
17. Hepatic functional scintigraphic imaging with 99mtechnetium galactosyl serum albumin.
Kubota Y; Kitagawa S; Inoue K; Ha-Kawa SK; Kojima M; Tanaka Y
Hepatogastroenterology; 1993 Feb; 40(1):32-6. PubMed ID: 8462925
[TBL] [Abstract][Full Text] [Related]
18. Measurement of functioning hepatocyte mass via [99mTc]galactosyl-neoglycoalbumin.
Kudo M; Vera DR; Stadalnik RC; Esquivel CO; Trudeau WL; Ikekubo K; Todo A
Dig Dis Sci; 1993 Dec; 38(12):2183-8. PubMed ID: 8261818
[TBL] [Abstract][Full Text] [Related]
19. Receptor measurements via Tc-GSA kinetic modeling are proportional to functional hepatocellular mass.
Miki K; Kubota K; Inoue Y; Vera DR; Makuuchi M
J Nucl Med; 2001 May; 42(5):733-7. PubMed ID: 11337568
[TBL] [Abstract][Full Text] [Related]
20. Discordant hepatic uptake of Tc-99m NGA and Tc-99m PMT in a patient with hepatoma.
Aburano T; Shuke N; Yokoyama K; Tonami N; Hisada K; Tanei M; Terada M; Unoura M; Kobayashi K
Clin Nucl Med; 1992 Oct; 17(10):793-6. PubMed ID: 1330392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
